RecruitingNCT06710665

Tumor Regression Grade As Predictor of Adjuvant Therapy

Tumor Regression Grade As Predictor of Adjuvant Therapy Benefits in Patients with Esophageal Squamous Cell Carcinoma After Neoadjuvant Therapy


Sponsor

Fujian Medical University Union Hospital

Enrollment

400 participants

Start Date

Oct 1, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Neoadjuvant therapy followed by surgery is preferred for locally advanced esophageal squamous cell carcinoma, but the necessity of adjuvant therapy remains controversial. Tumor regression grade reflects the response to neoadjuvant therapy and may predict patient prognosis, yet its role in guiding adjuvant therapy remains unexplored.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study looks at whether measuring how much a tumor has shrunk after pre-surgery treatment (called tumor regression grade) can predict whether patients with esophageal cancer need additional therapy after surgery. **You may be eligible if...** - You had surgery to completely remove your esophageal cancer (R0 resection) with lymph node removal - You received pre-surgery treatment such as radiation, chemoradiation, or immunotherapy - You have squamous cell carcinoma of the esophagus **You may NOT be eligible if...** - Your medical records or follow-up information are incomplete - You have been diagnosed with more than one primary cancer Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGChemotherapy

Chemotherapy


Locations(1)

Fujian Medical University Union Hospital

Fuzhou, Fujian, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06710665


Related Trials